PRODUCT PACKAGING QUANTITY ISSUE

This adverse event was reported 0 times

These drugs are most commonly taken by patients reporting PRODUCT PACKAGING QUANTITY ISSUE:

# Drug Count
0 LEUPROLIDE ACETATE 670
1 ALBUTEROL SULFATE 612
2 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 313
3 ALBUTEROL 295
4 ESTRADIOL 292
5 CYCLOSPORINE 246
6 RIVAROXABAN 211
7 BIMATOPROST 209
8 APIXABAN 190
9 BUPRENORPHINE 186
See all common drugs associated with PRODUCT PACKAGING QUANTITY ISSUE

PRODUCT PACKAGING QUANTITY ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 160 0.0771
1 Oxaborole Antifungal [EPC] 4 0.0571
2 Gonadotropin [EPC] 76 0.0347
3 Macrolide Antibacterial [EPC] 29 0.0287
4 Polymyxin-class Antibacterial [EPC] 2 0.0274
5 Semifluorinated Alkane [EPC] 62 0.0267
6 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 172 0.0104
7 Provitamin D2 Compound [EPC] 164 0.0055
8 Calcitonin [EPC] 17 0.0054
9 Prostaglandin Analog [EPC] 503 0.0054
See all drug classes enriched for association with PRODUCT PACKAGING QUANTITY ISSUE